The phosphodiesterase 5 inhibitor, sildenafil, further augments the compensatory upregulation of NO-cGMP signalling in hypoxic pulmonary hypertension
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2210
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The phosphodiesterase 5 inhibitor, sildenafil, further augments the compensatory upregulation of NO-cGMP signalling in hypoxic pulmonary hypertension ; volume:5 ; number:1 ; day:16 ; month:6 ; year:2005 ; pages:1 ; date:6.2005
BMC pharmacology ; 5, Heft 1 (16.6.2005), 1, 6.2005
- Creator
-
Kirsch, Mark
Weissmann, Norbert
Kemp-Harper, Barbara
Grimminger, Friedrich
Schmidt, Harald HHW
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2210-5-S1-P26
- URN
-
urn:nbn:de:101:1-2021081622062902308268
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kirsch, Mark
- Weissmann, Norbert
- Kemp-Harper, Barbara
- Grimminger, Friedrich
- Schmidt, Harald HHW
- SpringerLink (Online service)
Other Objects (12)
Die Phosphodiesterase-Hemmer Sildenafil und Amrinon zur Therapie des Mendelson-Syndroms
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
Phosphodiesterase 9 in ventilator-induced lung injury and hypoxic pulmonary vasoconstriction
Sildenafil
Bifunctional Sildenafil Diazeniumdiolates Acting as Phosphodiesterase 5 Inhibitors and Nitric Oxide Donors− Towards Wound Healing
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain
Verbesserung der endothelabhängigen und -unabhängigen Gefäßrelaxation durch Behandlung mit dem Phosphodiesterase 5-Inhibitor Sildenafil im experimentellen Diabetesmodell
Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension
Die Phosphodiesterase-Hemmer Sildenafil und Amrinon zur Therapie des Mendelson-Syndroms
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
Phosphodiesterase 9 in ventilator-induced lung injury and hypoxic pulmonary vasoconstriction
Sildenafil
Bifunctional Sildenafil Diazeniumdiolates Acting as Phosphodiesterase 5 Inhibitors and Nitric Oxide Donors− Towards Wound Healing
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain
Verbesserung der endothelabhängigen und -unabhängigen Gefäßrelaxation durch Behandlung mit dem Phosphodiesterase 5-Inhibitor Sildenafil im experimentellen Diabetesmodell
Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension
Die Phosphodiesterase-Hemmer Sildenafil und Amrinon zur Therapie des Mendelson-Syndroms
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Untersuchung der Wirkung des Phosphodiesterase-Inhibitors Sildenafil in Kombination mit Chemotherapie beim Pankreaskarzinom
Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
Phosphodiesterase 9 in ventilator-induced lung injury and hypoxic pulmonary vasoconstriction
Sildenafil
Bifunctional Sildenafil Diazeniumdiolates Acting as Phosphodiesterase 5 Inhibitors and Nitric Oxide Donors− Towards Wound Healing
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain
Verbesserung der endothelabhängigen und -unabhängigen Gefäßrelaxation durch Behandlung mit dem Phosphodiesterase 5-Inhibitor Sildenafil im experimentellen Diabetesmodell